Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology
Reference9 articles.
1. Birkmayer, W., Hornykiewicz, O. Der L-3, 4-Dioxyphenylalanin(=Dopa)-Effekt beim Parkinson-Syndrom des Menschen. Arch. Psychiat. Nervenkr.203, 560?574 (1962).
2. Birkmayer, W., Hornykiewicz, O. Advances in Parkinsonism, pp. 381?396. Basle: Editiones Roche. 1976.
3. Birkmayer, W., Neumayer, E. Die moderne medikamentöse Behandlung des Parkinsonismus. Z. Neurol.202, 257 (1972).
4. Birkmayer, W., Riederer, P., Youdim, M. B. H., Linauer, W. The potentiation of the anti-akinetic effect after L-DOPA treatment by an inhibitor of MAO-B, deprenyl. J. Neural Transm.36, 303?326 (1975).
5. Birkmayer, W., Riederer, P., Ambrozi, L., Youdim, M. B. H. Implications of Combined Treatment with Madopar and L-Deprenyl in Parkinson's disease. Lancetii, 439?443 (1977).
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献